Evidence map›Paper›PMID 33888438›Full record

ArticleHipertension y riesgo vascular

2021 Spanish Society of Hypertension position statement about telemedicine.

T Gijón-Conde, E Rubio, M Gorostidi, E Vinyoles, P Armario, E Rodilla, J Segura, J A Divisón-Garrote, J A García-Donaire, A Molinero and 1 more

Open access · greenAbstract readConsensus Statement
In one paragraph

Article in Hipertension y riesgo vascular. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Guideline
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 9 institutions in 1 country.

T Gijón-CondeCentro de Salud Cerro del Aire, Departamento de Medicina, Universidad Autónoma Madrid/IdiPAZ y CIBERESP, Majadahonda, Madrid, Spain. Electronic address: gijonmt@gmail.com.
E RubioServicio de Nefrología, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain. Electronic address: erubio@salud.madrid.org.
M GorostidiServicio de Nefrología, Hospital Universitario Central de Asturias, RedinRen, Universidad de Oviedo, Oviedo, Spain.
E VinyolesCentre d'Atenció Primària La Mina, Departamento de Medicina, Universidad de Barcelona, Barcelona, Spain.
P ArmarioÁrea Atención Integrada de Riesgo Vascular, Departamento de Medicina Interna, Hospital Moisès Broggi Sant Joan Despi, Universidad de Barcelona, Sant Joan Despí, Barcelona, Spain.
E RodillaServicio de Medicina Interna, Hospital Universitario de Sagunto, Universidad Cardenal Herrera-CEU, Sagunto, Valencia, Spain.
J SeguraInstituto de Investigación i+12, Hospital Universitario 12 de Octubre, Madrid, Spain; Unidad de Hipertensión, Servicio de Nefrología, Hospital Universitario 12 de Octubre, Madrid, Spain.
J A Divisón-GarroteCentro de Salud de Casas Ibáñez, Universidad Católica San Antonio, Casas Ibáñez, Albacete, Spain.
J A García-DonaireUnidad de Hipertensión, Hospital Clínico San Carlos, Madrid, Spain.
A MolineroSociedad Española de Farmacia Comunitaria (SEFAC), Spain.
L M RuilopeInstituto de Investigación i+12, Hospital Universitario 12 de Octubre, Madrid, Spain; Unidad de Hipertensión, Servicio de Nefrología, Hospital Universitario 12 de Octubre, Madrid, Spain; Escuela de Estudios de Doctorado e Investigación, Universidad Europea de Madrid, Villaviciosa de Odón, Madrid, Spain.
Hospital Universitario 12 De Octubre · ESCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública · ESHospital Clínico San Carlos · ESHospital de Sagunto · ESHospital de Sant Joan Despí Moisès Broggi · ESHospital Universitario Puerta de Hierro Majadahonda · ESSociedad Española de Farmacología Clínica · ESUniversidad de Oviedo · ESUniversitat de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The pandemic caused by coronavirus SARS-CoV-2 (COVID-19) has forced, in many cases, to replace face-to-face consultation with the telematic consultation, in order to reduce the risk of contagion associated with the presence of patients in health centres. This change may represent an opportunity for a different and more effective communication between professionals and patients, allowing better accessibility to medical care and more systematic and comprehensive approach to patients with hypertension and cardiovascular risk. However, organisational tools are needed to facilitate communication between patients and professionals, specifically with the exchange of clinical data by remote monitoring of variables associated with hypertension and cardiovascular risk (blood pressure, weight, height, blood tests…), and allow monitoring of adherence to treatments, lifestyles and risk factors. It would be desirable for this to be carried out by multidisciplinary teams, both from primary care, hospital and community pharmacy, with an adequate coordination of care. This document of the Spanish Society of Hypertension (SEH-LELHA) tries to give the keys to improve the quality of care of telematic consultations of patients with hypertension and cardiovascular risk, provide basic criteria of telematic or face to face attention and systematise their content. Likewise, the follow-up criteria are proposed by the different professionals.

Indexed as

HypertensionTelemedicineAftercareBlood Pressure Monitoring, AmbulatoryConfidentialityEmergenciesHealth Services AccessibilityHumansLife StyleMedical History TakingPatient CompliancePatient Education as TopicPhysician-Patient RelationsPrimary Health CareQuality ImprovementSelf CareHipertensiónHypertensionTeleconsultaTeleconsultationTelemedicinaTelemedicine

Identifiers

PMID33888438
PMCPMC8054212
OpenAlexW3155659813

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.